GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Retail - Defensive » Eastwood Bio-Medical Canada Inc (TSXV:EBM) » Definitions » Gross Margin %
中文

Eastwood Bio-Medical Canada (TSXV:EBM) Gross Margin % : 69.65% (As of Jan. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Eastwood Bio-Medical Canada Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Eastwood Bio-Medical Canada's Gross Profit for the three months ended in Jan. 2024 was C$0.14 Mil. Eastwood Bio-Medical Canada's Revenue for the three months ended in Jan. 2024 was C$0.20 Mil. Therefore, Eastwood Bio-Medical Canada's Gross Margin % for the quarter that ended in Jan. 2024 was 69.65%.


The historical rank and industry rank for Eastwood Bio-Medical Canada's Gross Margin % or its related term are showing as below:

TSXV:EBM' s Gross Margin % Range Over the Past 10 Years
Min: 25.07   Med: 45.2   Max: 69.46
Current: 59.97


During the past 11 years, the highest Gross Margin % of Eastwood Bio-Medical Canada was 69.46%. The lowest was 25.07%. And the median was 45.20%.

TSXV:EBM's Gross Margin % is ranked better than
95.51% of 312 companies
in the Retail - Defensive industry
Industry Median: 22.73 vs TSXV:EBM: 59.97

Eastwood Bio-Medical Canada had a gross margin of 69.65% for the quarter that ended in Jan. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Eastwood Bio-Medical Canada was 9.10% per year.


Eastwood Bio-Medical Canada Gross Margin % Historical Data

The historical data trend for Eastwood Bio-Medical Canada's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eastwood Bio-Medical Canada Gross Margin % Chart

Eastwood Bio-Medical Canada Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43.70 25.07 46.69 69.46 63.13

Eastwood Bio-Medical Canada Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 74.40 57.73 67.38 37.98 69.65

Competitive Comparison of Eastwood Bio-Medical Canada's Gross Margin %

For the Food Distribution subindustry, Eastwood Bio-Medical Canada's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eastwood Bio-Medical Canada's Gross Margin % Distribution in the Retail - Defensive Industry

For the Retail - Defensive industry and Consumer Defensive sector, Eastwood Bio-Medical Canada's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Eastwood Bio-Medical Canada's Gross Margin % falls into.



Eastwood Bio-Medical Canada Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Eastwood Bio-Medical Canada's Gross Margin for the fiscal year that ended in Oct. 2023 is calculated as

Gross Margin % (A: Oct. 2023 )=Gross Profit (A: Oct. 2023 ) / Revenue (A: Oct. 2023 )
=0.5 / 0.868
=(Revenue - Cost of Goods Sold) / Revenue
=(0.868 - 0.32) / 0.868
=63.13 %

Eastwood Bio-Medical Canada's Gross Margin for the quarter that ended in Jan. 2024 is calculated as


Gross Margin % (Q: Jan. 2024 )=Gross Profit (Q: Jan. 2024 ) / Revenue (Q: Jan. 2024 )
=0.1 / 0.201
=(Revenue - Cost of Goods Sold) / Revenue
=(0.201 - 0.061) / 0.201
=69.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Eastwood Bio-Medical Canada  (TSXV:EBM) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Eastwood Bio-Medical Canada had a gross margin of 69.65% for the quarter that ended in Jan. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Eastwood Bio-Medical Canada Gross Margin % Related Terms

Thank you for viewing the detailed overview of Eastwood Bio-Medical Canada's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Eastwood Bio-Medical Canada (TSXV:EBM) Business Description

Traded in Other Exchanges
N/A
Address
4871 Shell Road, Suite 1130, Richmond, BC, CAN, V6X 3Z6
Eastwood Bio-Medical Canada Inc is a Canadian company engaged in the development and commercialization of safe and effective treatment for non-insulin dependent diabetes mellitus. The company is engaged in natural health supplement distribution company. It has its geographic presence in North America, Canada and Asia.

Eastwood Bio-Medical Canada (TSXV:EBM) Headlines

No Headlines